Behzad Hajarizadeh

Nov 7, 2023 | onlinelibrary.wiley.com | Marianne Byrne |Behzad Hajarizadeh |Joanne Carson |Jason Grebely

1 INTRODUCTION Injecting drug use is the primary mode of hepatitis C virus (HCV) transmission across the world, particularly in high-income countries.1, 2 People who inject drugs are over-represented in prisons in most countries, primarily for drug-related offences,3 with an estimated 58% of people who inject drugs having an incarceration history globally.4 People in prison are at increased risk of HCV infection given high prevalence of injecting drug use and limited access to harm reduction...

May 30, 2023 | onlinelibrary.wiley.com | Heather Valerio |Maryam Alavi |Alison D. Marshall |Behzad Hajarizadeh

CONFLICT OF INTEREST STATEMENT Gregory J. Dore reports research support from Gilead and Abbvie. Jason Grebely  is a consultant or adviser for and has received research grants from AbbVie, Biolytical, Camurus, Cepheid, Gilead Sciences, Hologic, Indivor and Merck, and has received honoraria from AbbVie, Cepheid, Gilead Sciences and Merck outside the submitted work.